InsidersTradesSigma
Explore the full record of transactions filed by Karen AIACH, Chief Executive Officer. Director active across 1 companies, notably LYSOGENE. Aggregated, 1 reports have been published. Total volume traded: €357k. The latest transaction was filed on 2 June 2022 (Acquisition). Regulator: AMF. All data is free.
1 of 1 declaration
Karen Aiach is the Chairman & CEO of LYSOGENE. She leads the company's operations and oversees the implementation of its strategy. Her expertise in the biopharmaceutical field is an asset for developing new solutions.